Nicotinamide adenine dinucleotide phosphate oxidase-mediated redox signaling and vascular remodeling by 16α-hydroxyestrone in human pulmonary artery cells

Hypertension

Volumn 68, Issue 3, 2016, Pages 796-808

  Hood, Katie Y ^a   Montezano, Augusto C ^a   Harvey, Adam P ^a   Nilsen, Margaret ^a   Maclean, Margaret R ^a   Touyz, Rhian M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

estrogens; hypertension, pulmonary; models, animal; NADPH oxidase; superoxide

Indexed keywords

16ALPHA HYDROXYESTRONE; ANTIOXIDANT; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; OXIDOREDUCTASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ESTRONE DERIVATIVE; NOX1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; VASCULAR REMODELING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; FEMALE; HUMANS; HYDROXYESTRONES; HYPERTENSION, PULMONARY; MICE; NADP; NADPH OXIDASE; OXIDATION-REDUCTION; PULMONARY ARTERY; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

EID: 84978035380     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07668     Document Type: Article

References (45)

1. White K, Johansen AK, Nilsen M, Ciuclan L, Wallace E, Paton L, Campbell A, Morecroft I, Loughlin L, McClure JD, Thomas M, Mair KM, MacLean MR, Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension. Circulation 2012 126 1087 1098. doi: 10.1161/CIRCULATIONAHA.111.062927
2. Mair KM, Yang XD, Long L, White K, Wallace E, Ewart MA, Docherty CK, Morrell NW, MacLean MR, Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2015 191 693 703. doi: 10.1164/rccm.201410-1802OC
3. Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA, Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009 34 1093 1099. doi: 10.1183/09031936.00010409
4. Lahm T, Albrecht M, Fisher AJ, Selej M, Patel NG, Brown JA, Justice MJ, Brown MB, Van Demark M, Trulock KM, Dieudonne D, Reddy JG, Presson RG, Petrache I, 17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am J Respir Crit Care Med 2012 185 965 980. doi: 10.1164/rccm.201107-1293OC
5. Frump AL, Goss KN, Vayl A, Albrecht M, Fisher A, Tursunova R, Fierst J, Whitson J, Cucci AR, Brown MB, Lahm T, Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am J Physiol Lung Cell Mol Physiol 2015 308 L873 L890. doi: 10.1152/ajplung.00006.2015
6. Tofovic SP, Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease. J Cardiovasc Pharmacol 2010 56 696 708. doi: 10.1097/FJC.0b013e3181f9ea8d
7. Dubey RK, Jackson EK, Gillespie DG, Rosselli M, Barchiesi F, Krust A, Keller H, Zacharia LC, Imthurn B, Cytochromes 1A1/1B1-And catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab 2005 90 247 255. doi: 10.1210/jc.2003-032154
8. Napoli N, Rini GB, Serber D, Giri T, Yarramaneni J, Bucchieri S, Camarda L, Di Fede G, Camarda MR, Jain S, Mumm S, Armamento-Villareal R, The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density. Bone 2009 44 442 448. doi: 10.1016/j.bone.2008.09.018
9. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP, 2-hydroxyestrone: the 'good' estrogen. J Endocrinol 1996 150 suppl S259 S265
10. Badawi AF, Cavalieri EL, Rogan EG, Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 2001 50 1001 1003. doi: 10.1053/meta.2001.25592
11. West J, Cogan J, Geraci M, Robinson L, Newman J, Phillips JA, Lane K, Meyrick B, Loyd J, Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics 2008 1 45. doi: 10.1186/1755-8794-1-45
12. Ventetuolo CE, Mitra N, Wan F, Manichaikul A, Barr RG, Johnson C, Bluemke DA, Lima JA, Tandri H, Ouyang P, Kawut SM, Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function. Eur Respir J 2016 47 553 563. doi: 10.1183/13993003.01083-2015
13. Mueck AO, Seeger H, Lippert TH, Estradiol metabolism and malignant disease. Maturitas 2002 43 1 10
14. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL, Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992 84 634 638
15. Johar R, Sharma R, Kaur A, Mukherjee TK, Role of reactive oxygen species in estrogen dependant breast cancer complication. Anticancer Agents Med Chem 2015 16 190 199
16. Liu B, Luo XJ, Yang ZB, Zhang JJ, Li TB, Zhang XJ, Ma QL, Zhang GG, Hu CP, Peng J, Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats. J Cardiovasc Pharmacol 2014 63 567 576. doi: 10.1097/FJC.0000000000000082
17. Frazziano G, Al Ghouleh I, Baust J, Shiva S, Champion HC, Pagano PJ, Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4. Am J Physiol Heart Circ Physiol 2014 306 H197 H205. doi: 10.1152/ajpheart.00977.2012
18. Veit F, Pak O, Egemnazarov B, Roth M, Kosanovic D, Seimetz M, Sommer N, Ghofrani HA, Seeger W, Grimminger F, Brandes RP, Schermuly RT, Weissmann N, Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. Antioxid Redox Signal 2013 19 2213 2231. doi: 10.1089/ars.2012.4904
19. Lopes RA, Neves KB, Tostes RC, Montezano AC, Touyz RM, Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension 2015 66 1240 1250. doi: 10.1161/HYPERTENSIONAHA.115.06163
20. Touyz R, Schiffrin E, Ang II-stimulated generation of vascular smooth muscle cell reactive oxygen species is increased in human hypertension: role of phospholipase d. Circulation 1999 100 479 479
21. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL, Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004 22 1141 1149
22. Persson C, Kappert K, Engström U, Ostman A, Sjöblom T, An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases. Methods 2005 35 37 43. doi: 10.1016/j.ymeth.2004.07.006
23. Chignalia AZ, Schuldt EZ, Camargo LL, Montezano AC, Callera GE, Laurindo FR, Lopes LR, Avellar MC, Carvalho MH, Fortes ZB, Touyz RM, Tostes RC, Testosterone induces vascular smooth muscle cell migration by NADPH oxidase and c-Src-dependent pathways. Hypertension 2012 59 1263 1271. doi: 10.1161/HYPERTENSIONAHA.111.180620
24. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 2010 160 1573 1576. doi: 10.1111/j.1476-5381.2010.00873.x
25. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP, Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 2012 110 1217 1225. doi: 10.1161/CIRCRESAHA.112.267054
26. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C, Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 2005 112 2677 2685. doi: 10.1161/CIRCULATIONAHA.105.573709
27. Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR, Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circ Res 2001 89 1231 1239
28. Lawrie A, Hameed AG, Chamberlain J, Arnold N, Kennerley A, Hopkinson K, Pickworth J, Kiely DG, Crossman DC, Francis SE, Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. Am J Pathol 2011 179 1693 1705. doi: 10.1016/j.ajpath.2011.06.037
29. Hameed AG, Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW, Crossman DC, Newman CM, Kiely DG, Francis SE, Lawrie A, Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. J Exp Med 2012 209 1919 1935. doi: 10.1084/jem.20112716
30. Van den Bergh A, Flameng W, Herijgers P, Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state. Pflugers Arch 2008 455 987 994. doi: 10.1007/s00424-007-0362-8
31. Bretones G, Delgado MD, León J, Myc and cell cycle control. Biochim Biophys Acta 2015 1849 506 516. doi: 10.1016/j.bbagrm.2014.03.013
32. Sweeney L, Voelkel NF, Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension. Eur J Med Res 2009 14 433 442
33. Chen X, Talati M, Fessel JP, Hemnes AR, Gladson S, French J, Shay S, Trammell A, Phillips JA, Hamid R, Cogan JD, Dawson EP, Womble KE, Hedges LK, Martinez EG, Wheeler LA, Loyd JE, Majka SJ, West J, Austin ED, Estrogen metabolite 16alpha-hydroxyestrone exacerbates bone morphogenetic protein receptor type II-Associated pulmonary arterial hypertension through microRNA-29-mediated modulation of cellular metabolism. Circulation 2016 133 82 97. doi: 10.1161/CIRCULATIONAHA.115.016133
34. Nilsson S, Gustafsson JÅ Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011 89 44 55. doi: 10.1038/clpt.2010.226
35. Wright AF, Ewart MA, Mair K, Nilsen M, Dempsie Y, Loughlin L, Maclean MR, Oestrogen receptor alpha in pulmonary hypertension. Cardiovasc Res 2015 106 206 216. doi: 10.1093/cvr/cvv106
36. Mair KM, Johansen AK, Wright AF, Wallace E, MacLean MR, Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol 2014 171 567 579. doi: 10.1111/bph.12281
37. Umar S, Iorga A, Matori H, Nadadur RD, Li J, Maltese F, van der Laarse A, Eghbali M, Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med 2011 184 715 723. doi: 10.1164/rccm.201101-0078OC
38. Yager JD, Liehr JG, Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996 36 203 232. doi: 10.1146/annurev.pa.36.040196.001223
39. Mittal M, Roth M, König P, Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 2007 101 258 267. doi: 10.1161/CIRCRESAHA.107.148015
40. Dennis KE, Aschner JL, Milatovic D, Schmidt JW, Aschner M, Kaplowitz MR, Zhang Y, Fike CD, NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 2009 297 L596 L607. doi: 10.1152/ajplung.90568.2008
41. Liu JQ, Zelko IN, Erbynn EM, Sham JS, Folz RJ, Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 2006 290 L2 10. doi: 10.1152/ajplung.00135.2005
42. Gray SP, Di Marco E, Kennedy K, Chew P, Okabe J, El-Osta A, Calkin AC, Biessen EA, Touyz RM, Cooper ME, Schmidt HH, Jandeleit-Dahm KA, Reactive oxygen species can provide atheroprotection via Nox4-dependent inhibition of inflammation and vascular remodeling. Arterioscler Thromb Vasc Biol 2016 36 295 307. doi: 10.1161/ATVBAHA.115.307012
43. Frijhoff J, Dagnell M, Godfrey R, Ostman A, Regulation of protein tyrosine phosphatase oxidation in cell adhesion and migration. Antioxid Redox Signal 2014 20 1994 2010. doi: 10.1089/ars.2013.5643
44. Bowling MR, Xing D, Kapadia A, Chen YF, Szalai AJ, Oparil S, Hage FG, Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors. Arterioscler Thromb Vasc Biol 2014 34 1477 1485. doi: 10.1161/ATVBAHA.114.303629
45. Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, Hart CM, The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol 2012 47 718 726. doi: 10.1165/rcmb.2011-0418OC